It has also been reported that under conditions of ACE inhibition, DPP-4 plays a significant role in the degradation and inactivation of substance P. Brown et al. reported that concurrent DPP-4 inhibitor and ACE inhibitor use increases the risk of vasoactive peptide-induced angioedema [5]. This evidence concerns the gene DPP4 and angioedema.